Percutaneous Hepatic Perfusion (PHP)
Cancer specialists at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore are testing a new procedure to treat melanoma that has spread to the liver, targeting tumors with a dose of chemotherapy that is 10 times stronger than patients could otherwise tolerate.
The procedure is called Percutaneous Hepatic Perfusion. Doctors use a specially designed delivery system with catheters and filters to make sure the cancer-fighting drug is applied only to the liver, thereby reducing the risk of damaging nearby organs and minimizing possible side effects for patients.
This page was last updated: August 7, 2013